Tracking LENZ historical volatility helps you see how much LENZ Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, LENZ Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor LENZ 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The LENZ 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing LENZ Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts LENZ Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where LENZ HV is running hot, cold, or in line. Make the LENZ 30 day historical volatility — and every other window — work for your edge instead of against it.
